Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of N-1-benzyl and N-1-[3-methylbutyl]-4-hydroxy-1,8-naphthyridon-3-yl benzothiadiazine analogs containing substituents on the aromatic ring.

[1]  A. Gopalsamy,et al.  Design and synthesis of 3,4-dihydro-1H-[1]-benzothieno[2,3-c]pyran and 3,4-dihydro-1H-pyrano[3,4-b]benzofuran derivatives as non-nucleoside inhibitors of HCV NS5B RNA dependent RNA polymerase. , 2006, Bioorganic & medicinal chemistry letters.

[2]  N. Walker,et al.  SAR and mode of action of novel non-nucleoside inhibitors of hepatitis C NS5b RNA polymerase. , 2006, Journal of medicinal chemistry.

[3]  Dashyant Dhanak,et al.  3-(1,1-dioxo-2H-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1H)-quinolinones, potent inhibitors of hepatitis C virus RNA-dependent RNA polymerase. , 2006, Journal of medicinal chemistry.

[4]  Michael Rowley,et al.  Potent inhibitors of subgenomic hepatitis C virus RNA replication through optimization of indole-N-acetamide allosteric inhibitors of the viral NS5B polymerase. , 2005, Journal of medicinal chemistry.

[5]  Jeffrey A Pfefferkorn,et al.  Inhibitors of HCV NS5B polymerase. Part 1: Evaluation of the southern region of (2Z)-2-(benzoylamino)-3-(5-phenyl-2-furyl)acrylic acid. , 2005, Bioorganic & medicinal chemistry letters.

[6]  A. Molla,et al.  Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of N-1-heteroalkyl-4-hydroxyquinolon-3-yl-benzothiadiazines. , 2005, Bioorganic & medicinal chemistry letters.

[7]  George Burton,et al.  Identification of small molecule inhibitors of the hepatitis C virus RNA-dependent RNA polymerase from a pyrrolidine combinatorial mixture. , 2005, Bioorganic & medicinal chemistry letters.

[8]  Paul A Keller,et al.  Control of hepatitis C: a medicinal chemistry perspective. , 2005, Journal of medicinal chemistry.

[9]  A. Gopalsamy,et al.  Identification of [(naphthalene-1-carbonyl)-amino]-acetic acid derivatives as nonnucleoside inhibitors of HCV NS5B RNA dependent RNA polymerase. , 2004, Bioorganic & medicinal chemistry letters.

[10]  P. Shetty.  Putting pain to bed Linda Stratmann Chloroform: the ques , 2004, The Lancet.

[11]  Quanlai Song,et al.  Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymerase. , 2004, Journal of medicinal chemistry.

[12]  M. Yuen,et al.  Viral hepatitis C , 2003, The Lancet.

[13]  S. Lemon,et al.  Selectable Subgenomic and Genome-Length Dicistronic RNAs Derived from an Infectious Molecular Clone of the HCV-N Strain of Hepatitis C Virus Replicate Efficiently in Cultured Huh7 Cells , 2002, Journal of Virology.

[14]  C. Rice,et al.  Efficient initiation of HCV RNA replication in cell culture. , 2000, Science.

[15]  N. Zein.  Clinical Significance of Hepatitis C Virus Genotypes , 2000, Clinical Microbiology Reviews.

[16]  J. Rokach,et al.  A new synthesis of 1,2,4-benzothiadiazines and a selective preparation of o-aminobenzenesulphonamides , 1979 .

[17]  J. Topliss,et al.  ANTIHYPERTENSIVE AGENTS. I. NON-DIURETIC 2H-1,2,4-BENZOTHIADIAZINE 1,1-DIOXIDES. , 1963, Journal of medicinal chemistry.